Capstone Investment Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-7,500
Closed -$1.32M – 2068
2025
Q2
$1.32M Buy
+7,500
New +$1.13M ﹤0.01% 771
2014
Q1
– Sell
-82,900
Closed -$3.49M – 526
2013
Q4
$3.49M Buy
82,900
+35,300
+74% +$1.54M 0.04% 249
2013
Q3
$1.96M Hold
47,600
– – 0.02% 345
2013
Q2
$2.19M Buy
+47,600
New +$2.13M 0.02% 240

Other funds holding THC

Capstone Investment Advisors's THC Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 1,299 shares — an estimated $245K sold.

Capstone Investment Advisors first reported a position in THC in Q4 2013 and held it in 5 quarters. The position peaked at $4.28M in Q1 2014. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,299 Tenet Healthcare shares in Q2 2026, an estimated $245K.
  • Capstone Investment Advisors first reported a position in Tenet Healthcare in Q4 2013 and held it in 5 quarters.
  • Capstone Investment Advisors's Tenet Healthcare position peaked at $4.28M in Q1 2014.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.